Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07492836 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypofractionated Radiotherapy Plus Temozolamide in Patients Younger Than 70 Years With Glioblastoma

Study acronym: HipoGBM
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
1,251 trials monitored
See 88 trials at risk
710 trials monitored
See 52 trials at risk
The goal of this clinical trial is to evaluate the feasibility, safety and effectiveness of radiotherapy with fewer days of treatment and a higher dose of radiation each day in patients under 70 years of age diagnosed with a brain tumor known as glioblastoma.
Trial Details
NCT Number NCT07492836
Lead Sponsor Hospital do Coracao
Conditions
(from sponsor)
Glioblastoma (GBM)
Related terms Glioblastoma
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov